SANOFI INDIA
|
SANOFI INDIA Last 5 Year Financial Ratios History
[Standalone]
| Dec2025 | Dec2024 | Dec2023 | Dec2022 | Dec2021 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 142.04 | 136.39 | 158.52 | 269.83 | 410.61 |
| CEPS(Rs) | 158.26 | 152.35 | 174.39 | 288.04 | 439.61 |
| DPS(Rs) | 123.00 | 117.00 | 167.00 | 570.00 | 490.00 |
| Book NAV/Share(Rs) | 294.48 | 343.96 | 411.83 | 527.65 | 941.52 |
| Tax Rate(%) | 26.53 | 27.28 | 31.01 | 28.20 | 24.90 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 23.63 | 22.14 | 23.50 | 24.09 | 25.78 |
| EBIT Margin(%) | 21.47 | 19.55 | 25.58 | 29.68 | 42.60 |
| Pre Tax Margin(%) | 21.39 | 19.48 | 25.50 | 29.62 | 42.54 |
| PAT Margin (%) | 15.71 | 14.17 | 17.59 | 21.27 | 31.94 |
| Cash Profit Margin (%) | 17.51 | 15.82 | 19.35 | 22.70 | 34.20 |
| Performance Ratios | |||||
| ROA(%) | 7.18 | 6.69 | 7.65 | 11.95 | 17.74 |
| ROE(%) | 44.50 | 36.09 | 33.75 | 36.73 | 44.65 |
| ROCE(%) | 55.46 | 46.15 | 46.28 | 49.47 | 57.98 |
| Asset Turnover(x) | 0.46 | 0.47 | 0.43 | 0.56 | 0.56 |
| Sales/Fixed Asset(x) | 3.60 | 3.99 | 3.86 | 5.42 | 4.23 |
| Working Capital/Sales(x) | 6.73 | 5.67 | 3.48 | 3.36 | 2.13 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.28 | 0.25 | 0.26 | 0.18 | 0.24 |
| Receivable days | 35.69 | 29.81 | 22.96 | 17.01 | 17.96 |
| Inventory Days | 71.21 | 95.89 | 94.36 | 50.06 | 46.94 |
| Payable days | 122.11 | 130.04 | 124.01 | 112.47 | 97.06 |
| Valuation Parameters | |||||
| PER(x) | 28.81 | 44.88 | 50.89 | 21.68 | 19.22 |
| PCE(x) | 25.85 | 40.18 | 46.26 | 20.31 | 17.95 |
| Price/Book(x) | 13.89 | 17.80 | 19.59 | 11.09 | 8.38 |
| Yield(%) | 3.01 | 1.91 | 2.07 | 9.74 | 6.21 |
| EV/Net Sales(x) | 4.97 | 6.85 | 9.09 | 4.49 | 5.62 |
| EV/Core EBITDA(x) | 17.88 | 27.17 | 33.07 | 16.03 | 19.84 |
| EV/EBIT(x) | 20.47 | 31.84 | 34.23 | 14.36 | 13.18 |
| EV/CE(x) | 12.19 | 16.02 | 17.87 | 9.75 | 2.99 |
| M Cap / Sales | 5.12 | 6.99 | 9.30 | 4.86 | 6.14 |
| Growth Ratio | |||||
| Net Sales Growth(%) | -8.73 | 0.86 | -27.94 | -6.31 | 1.88 |
| Core EBITDA Growth(%) | 0.73 | -7.58 | -29.26 | -7.29 | 4.23 |
| EBIT Growth(%) | 3.12 | -18.35 | -38.78 | -31.24 | 85.48 |
| PAT Growth(%) | 4.14 | -13.96 | -41.25 | -34.29 | 97.74 |
| EPS Growth(%) | 4.14 | -13.96 | -41.25 | -34.29 | 97.74 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | - | - | - | - | - |
| Current Ratio(x) | 1.12 | 1.15 | 1.23 | 1.32 | 1.60 |
| Quick Ratio(x) | 1.00 | 0.96 | 0.97 | 1.17 | 1.43 |
| Interest Cover(x) | 262.59 | 288.60 | 311.88 | 509.41 | 699.67 |
| Total Debt/Mcap(x) | - | - | - | - | - |
Compare Financial Ratios of peers of SANOFI INDIA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SANOFI INDIA | ₹7,980.0 Cr | 6.3% | -8.4% | -41.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹412,050.0 Cr | 1.3% | -4.5% | -0% | Stock Analytics | |
| DIVIS LABORATORIES | ₹158,157.0 Cr | 1.7% | -5.9% | 3.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹138,531.0 Cr | 2.6% | -5% | 25.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,190.0 Cr | -0.4% | -7% | 3.6% | Stock Analytics | |
| CIPLA | ₹98,892.8 Cr | 2.6% | -7.4% | -16.3% | Stock Analytics | |
SANOFI INDIA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SANOFI INDIA | 6.3% |
-8.4% |
-41.7% |
| SENSEX | 4.8% |
-4.2% |
0.8% |
You may also like the below Video Courses
